These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35039753)

  • 1. Exosomes and COVID-19: challenges and opportunities.
    Babaei G; Zare N; Mihanfar A; Ansari MHK
    Comp Clin Path; 2022; 31(2):347-354. PubMed ID: 35039753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of extracellular vesicles in COVID-19 virus infection.
    Hassanpour M; Rezaie J; Nouri M; Panahi Y
    Infect Genet Evol; 2020 Nov; 85():104422. PubMed ID: 32544615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
    Gurunathan S; Kang MH; Kim JH
    Front Immunol; 2021; 12():716407. PubMed ID: 34394121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
    Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
    Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment.
    Rezaei Z; Mobasheri L; Sadri F
    DNA Cell Biol; 2021 Jul; 40(7):858-868. PubMed ID: 33989051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
    Sur S; Steele R; Isbell TS; Ray R; Ray RB
    mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes: Applications in Respiratory Infectious Diseases and Prospects for Coronavirus Disease 2019 (COVID-19).
    Feng J; Waqas A; Zhu Z; Chen L
    J Biomed Nanotechnol; 2020 Apr; 16(4):399-418. PubMed ID: 32970974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.
    Zani-Ruttenstock E; Antounians L; Khalaj K; Figueira RL; Zani A
    Eur J Pediatr Surg; 2021 Aug; 31(4):326-334. PubMed ID: 34161984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
    Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
    Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome therapeutics for COVID-19 and respiratory viruses.
    Popowski KD; Dinh PC; George A; Lutz H; Cheng K
    View (Beijing); 2021 Jun; 2(3):20200186. PubMed ID: 34766162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
    Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M
    Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms.
    Kaffash Farkhad N; Mahmoudi A; Mahdipour E
    Regen Ther; 2022 Jun; 20():61-71. PubMed ID: 35340407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective.
    Khan S; Tombuloglu H; Hassanein SE; Rehman S; Bozkurt A; Cevik E; Abdel-Ghany S; Nabi G; Ali A; Sabit H
    Eur J Pharmacol; 2020 Nov; 886():173447. PubMed ID: 32763302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.
    Dashraath P; Wong JLJ; Lim MXK; Lim LM; Li S; Biswas A; Choolani M; Mattar C; Su LL
    Am J Obstet Gynecol; 2020 Jun; 222(6):521-531. PubMed ID: 32217113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.